BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 28947471)

  • 1. SPR741, an Antibiotic Adjuvant, Potentiates the
    Zurawski DV; Reinhart AA; Alamneh YA; Pucci MJ; Si Y; Abu-Taleb R; Shearer JP; Demons ST; Tyner SD; Lister T
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28947471
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical and in vitro efficacy of colistin plus vancomycin and rifampin against colistin-resistant Acinetobacter baumannii causing ventilator-associated pneumonia.
    Oliva A; Cipolla A; Vullo V; Venditti M; Mastroianni CM; Falcone M
    New Microbiol; 2017 Jul; 40(3):205-207. PubMed ID: 28675246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colistin and rifampicin combination in the treatment of ventilator-associated pneumonia caused by carbapenem-resistant Acinetobacter baumannii.
    Song JY; Lee J; Heo JY; Noh JY; Kim WJ; Cheong HJ; Hwang IS
    Int J Antimicrob Agents; 2008 Sep; 32(3):281-4. PubMed ID: 18650070
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of the clinical efficacy between tigecycline plus extended-infusion imipenem and sulbactam plus imipenem against ventilator-associated pneumonia with pneumonic extensively drug-resistant Acinetobacter baumannii bacteremia, and correlation of clinical efficacy with in vitro synergy tests.
    Jean SS; Hsieh TC; Hsu CW; Lee WS; Bai KJ; Lam C
    J Microbiol Immunol Infect; 2016 Dec; 49(6):924-933. PubMed ID: 26341302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic options for Acinetobacter baumannii infections.
    Vila J; Pachón J
    Expert Opin Pharmacother; 2008 Mar; 9(4):587-99. PubMed ID: 18312160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AB5075, a Highly Virulent Isolate of Acinetobacter baumannii, as a Model Strain for the Evaluation of Pathogenesis and Antimicrobial Treatments.
    Jacobs AC; Thompson MG; Black CC; Kessler JL; Clark LP; McQueary CN; Gancz HY; Corey BW; Moon JK; Si Y; Owen MT; Hallock JD; Kwak YI; Summers A; Li CZ; Rasko DA; Penwell WF; Honnold CL; Wise MC; Waterman PE; Lesho EP; Stewart RL; Actis LA; Palys TJ; Craft DW; Zurawski DV
    mBio; 2014 May; 5(3):e01076-14. PubMed ID: 24865555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colistin-based treatment for extensively drug-resistant Acinetobacter baumannii pneumonia.
    Khawcharoenporn T; Pruetpongpun N; Tiamsak P; Rutchanawech S; Mundy LM; Apisarnthanarak A
    Int J Antimicrob Agents; 2014 Apr; 43(4):378-82. PubMed ID: 24613422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nosocomial Acinetobacter pneumonia: Treatment and prognostic factors in 356 cases.
    Özvatan T; Akalın H; Sınırtaş M; Ocakoğlu G; Yılmaz E; Heper Y; Kelebek N; İşçimen R; Kahveci F
    Respirology; 2016 Feb; 21(2):363-9. PubMed ID: 26635315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of intravenous plus intrathecal/intracerebral ventricle injection of polymyxin B for post-neurosurgical intracranial infections due to MDR/XDR
    Pan S; Huang X; Wang Y; Li L; Zhao C; Yao Z; Cui W; Zhang G
    Antimicrob Resist Infect Control; 2018; 7():8. PubMed ID: 29387342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular characterization of a multidrug-resistant/pandrug-resistant nosocomial polymicrobial infection with Klebsiella pneumoniae, Providencia rettgeri, and Acinetobacter baumannii from Rural Maharashtra, India.
    Karad DD; Somani Y; Khande H; Yadav B; Kharat AS
    Acta Biochim Pol; 2020 Jul; 67(3):387-392. PubMed ID: 32735431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Nosocomial pneumonia caused by multiresistant Acinetobacter baumanii treated by colistin and rifampicin].
    Motaouakkil S; Charra B; Hachimi A; Benslama A
    Ann Fr Anesth Reanim; 2006 May; 25(5):543-4. PubMed ID: 16488103
    [No Abstract]   [Full Text] [Related]  

  • 12. In vitro activity of doripenem alone and in multi-agent combinations against extensively drug-resistant Acinetobacter baumannii and Klebsiella pneumoniae.
    Clock SA; Tabibi S; Alba L; Kubin CJ; Whittier S; Saiman L
    Diagn Microbiol Infect Dis; 2013 Jul; 76(3):343-6. PubMed ID: 23601454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colistin and rifampicin in the treatment of nosocomial infections from multiresistant Acinetobacter baumannii.
    Motaouakkil S; Charra B; Hachimi A; Nejmi H; Benslama A; Elmdaghri N; Belabbes H; Benbachir M
    J Infect; 2006 Oct; 53(4):274-8. PubMed ID: 16442632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of ventilator associated pneumonia with a new antibiotic adjuvant entity (ceftriaxone+sulbactam+disodium edetate) - A novel approach to spare carbapenems.
    Sathe P; Maddani S; Kulkarni S; Munshi N
    J Crit Care; 2017 Oct; 41():145-149. PubMed ID: 28535440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lysine-Based Small Molecule Sensitizes Rifampicin and Tetracycline against Multidrug-Resistant
    Konai MM; Haldar J
    ACS Infect Dis; 2020 Jan; 6(1):91-99. PubMed ID: 31646866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of monotherapy and combined antibiotic therapy for carbapenem-resistant Acinetobacter baumannii pneumonia in an immunosuppressed mouse model.
    Song JY; Cheong HJ; Lee J; Sung AK; Kim WJ
    Int J Antimicrob Agents; 2009 Jan; 33(1):33-9. PubMed ID: 18835761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colistin vs. the combination of colistin and rifampicin for the treatment of carbapenem-resistant Acinetobacter baumannii ventilator-associated pneumonia.
    Aydemir H; Akduman D; Piskin N; Comert F; Horuz E; Terzi A; Kokturk F; Ornek T; Celebi G
    Epidemiol Infect; 2013 Jun; 141(6):1214-22. PubMed ID: 22954403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infections Due to Acinetobacter baumannii in the ICU: Treatment Options.
    Lynch JP; Zhanel GG; Clark NM
    Semin Respir Crit Care Med; 2017 Jun; 38(3):311-325. PubMed ID: 28578555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extensively Drug-Resistant Acinetobacter baumannii Nosocomial Pneumonia Successfully Treated with a Novel Antibiotic Combination.
    Zaidan N; Hornak JP; Reynoso D
    Antimicrob Agents Chemother; 2021 Oct; 65(11):e0092421. PubMed ID: 34370576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emergence of antimicrobial resistance among Acinetobacter species: a global threat.
    Clark NM; Zhanel GG; Lynch JP
    Curr Opin Crit Care; 2016 Oct; 22(5):491-9. PubMed ID: 27552304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.